ArticlemSphere2023
Bolaamphiphile Analogues of 12-bis-THA Cl
Open access · goldAbstract read
In one paragraph
Article in mSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 9 citations in OpenAlex.
- The use of Galleria mellonella to study microbial interactions, immune responses, and substrate interactions.Essays in biochemistry · 2026Review
- Tyrosine-capped gold nanoparticles enable cysteine-free peptide loading, enhancing the antipseudomonal efficacy of scorpion-derived AamAP1-Lys-NHJournal of materials chemistry. B · 2026Article
- SuperBola Cationic Biocides with an Extended Bolaamphiphilic Structure: How Much Is Too Much?ACS infectious diseases · 2026Article
- Triscationic bolaamphiphilic QACs - optimizing antibacterial therapeutic indices.Bioorganic & medicinal chemistry letters · 2026Article
- Fact-finding with fungi: A scoping review on recent advancements in the role of fungi as evidence in forensic science.International journal of legal medicine · 2026Article
- Cheap, Fast, Safe, Sustainable, and Positively Irresistible: The Future of Cationic Amphiphilic Disinfectant Development.Journal of medicinal chemistry · 2025Review
- Resorcinol-based Bolaamphiphilic Quaternary Ammonium Compounds.ChemMedChem · 2025Article
- Carboxy-Amidated AamAP1-Lys has Superior Conformational Flexibility and Accelerated Killing of Gram-Negative Bacteria.Biochemistry · 2025Article
- Highly Effective Biocides againstACS infectious diseases · 2024Article
- Carbon source competition within the wound microenvironment can significantly influence infection progression.NPJ biofilms and microbiomes · 2024Article
- Galleria mellonella-intracellular bacteria pathogen infection models: the ins and outs.FEMS microbiology reviews · 2023Review
- Synergy between Winter Flounder antimicrobial peptides.npj antimicrobials and resistance · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 5 institutions in 2 countries.
Simona Di BlasioInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.ORCID 0000-0002-3296-6155
Maria ClarkeInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.ORCID 0000-0003-4129-4810
Charlotte K HindTechnology Development Group, UK Health Security Agency, Research and Evaluation, Salisbury, United Kingdom.
Masanori AsaiSection of Paediatric Infectious Disease, Department of Infectious Disease, Imperial College London, London, United Kingdom.
Louis LaurenceNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Angelica BenvenutiInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Mahnoor HassanInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Dorothy SemenyaInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
DeDe Kwun-Wai ManInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Victoria HorrocksInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Giorgia ManzoInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Sarah Van Der LithInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Carolyn LamInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Eugenio GentileInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Callum AnnetteInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Janine BosseSection of Paediatric Infectious Disease, Department of Infectious Disease, Imperial College London, London, United Kingdom.ORCID 0000-0002-8491-4779
Yanwen LiSection of Paediatric Infectious Disease, Department of Infectious Disease, Imperial College London, London, United Kingdom.
Barry PanaretouInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Paul R LangfordSection of Paediatric Infectious Disease, Department of Infectious Disease, Imperial College London, London, United Kingdom.ORCID 0000-0002-6368-4724
Brian D RobertsonMRC Centre for Molecular Bacteriology and Infection, Department of Infectious Disease, Imperial College London, London, United Kingdom.
Jenny K W LamDepartment of Pharmacology & Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
J Mark SuttonInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Michael McArthurNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
A James MasonInstitute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.ORCID 0000-0003-0411-602X
King's College London · GBImperial College London · GBUniversity of East Anglia · GBUK Health Security Agency · GBUniversity College London · GB
Funding
Biotechnology and Biological Sciences Research Council BB/L013576/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/R001596/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/W002264/1Wellcome TrustWellcome Trust 204823/Z/16/Z
Abstract
12-Bis-THA Cl
Indexed as
Anti-Infective AgentsArthroplasty, Replacement, HipMethicillin-Resistant Staphylococcus aureusMothsAnimalsAnti-Bacterial AgentsDNAFemaleFuransHumansPyridonesAnti-Bacterial AgentsAnti-Infective AgentsbolaamphiphileDNAFuransPyridonesaminoglycosidesdequalinium chlorideGalleria mellonellasynergy
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.